Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Account Payables: 2010-2019

Historic Change in Account Payables for Sunshine Biopharma (SBFM) over the last 7 years, with Dec 2019 value amounting to $33,797.

  • Sunshine Biopharma's Change in Account Payables fell 49.57% to $33,797 in Q4 2019 from the same period last year, while for Dec 2019 it was -$18,692, marking a year-over-year decrease of 130.33%. This contributed to the annual value of -$35,012 for FY2020, which is 87.31% down from last year.
  • According to the latest figures from Q4 2019, Sunshine Biopharma's Change in Account Payables is $33,797, which was up 260.63% from -$21,040 recorded in Q3 2019.
  • Sunshine Biopharma's 5-year Change in Account Payables high stood at $342,944 for Q2 2017, and its period low was -$359,099 during Q3 2017.
  • For the 3-year period, Sunshine Biopharma's Change in Account Payables averaged around $2,844, with its median value being $3,022 (2018).
  • As far as peak fluctuations go, Sunshine Biopharma's Change in Account Payables crashed by 6,587.13% in 2018, and later spiked by 18,113.93% in 2019.
  • Quarterly analysis of 5 years shows Sunshine Biopharma's Change in Account Payables stood at $11,830 in 2015, then tumbled by 540.54% to $27,799 in 2016, then tumbled by 72.96% to $7,518 in 2017, then skyrocketed by 791.46% to $67,020 in 2018, then plummeted by 49.57% to $33,797 in 2019.
  • Its Change in Account Payables stands at $33,797 for Q4 2019, versus -$21,040 for Q3 2019 and $21,977 for Q2 2019.